The University of Rhode Island's Ryan Institute for Neuroscience is set to begin a pioneering trial of a new drug to treat Alzheimer's disease. Executive director Paula Grammas, associate director William Renehan and clinical programs coordinator Christine Getter discuss the trial -- and the role of inflammation in the currently incurable and invariably fatal disease affecting millions of Americans. Podcast by Providence Journal Staff Writer G. Wayne Miller.